Fuse Science Inc (DROP) 0.0002 $DROP
Spiral Energy Tech, Inc. Announces Patent Filing
ACCESSWIRE - Thu Nov 20, 5:16AM CST
LONG ISLAND, NY / ACCESSWIRE / November 20, 2014 / Spiral Energy Tech, Inc., ("SETI"
, a Fuse Science (OTC Pink: DROP) (PINKSHEETS: DROP) subsidiary, today announced that it has filed for Patent protection in the U.S. and foreign countries for the proprietary Drone support technology, Energy Demand Network or "EDEN". The proprietary technology enables the long distance flight required for drone based commerce without the need to return "home" every 15 minutes to recharge. The technology allows a drone operator to travel many miles outside of its "home range" allowing for a flight path of numerous miles limited only by our EDEN network of SkyPorts. This network is being developed for several states with planned nationwide deployment.
Bankruptcies, Breakouts, and Busts; What's Happening in Biotech?
ACCESSWIRE - Tue Nov 11, 10:34AM CST
CORAL GABLES, FL / ACCESSWIRE / November 11, 2014 / From prostate cancer drugs to stem-cell therapy, the biotech industry seems to encompass a variety of unique and innovative companies. According to market research firm IBISWorld, the global revenue of the Biotech industry is nearly $300 billion. Statista reports that more that $50Billion of US biopharmaceutical goods are exported and the industry is on pace to grow at a compounded annual rate of nearly 11%. IBIS notes that many small companies, alongside a few industry giants in pharmaceutical, chemical and agricultural firms, populate the global biotech industry. There is also a lower level of market share concentration as noted by IBISWorld estimates that the top four industry players will account for less than 28% of the industry's revenue in 2014. With so much potential there are certainly companies in the market, which have progressed to the next level and others that have mismanaged their businesses into bankruptcy.
DNDN: 0.13 (-0.02)
Fuse Science, Inc. Announces Restructuring, Acquisition and Completion of $1.6 Million Financing
ACCESSWIRE - Thu Oct 09, 5:21AM CDT
LONG ISLAND, NY / ACCESSWIRE / October 9, 2014 / Fuse Science, Inc. (OTC Pink: DROP) (PINKSHEETS: DROP) (the "Company" , today announced that it had completed a restructuring and financing with the purpose of supporting the Company's intent to expand its operations by entering into new lines of business.
Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018
PR Newswire - Wed Feb 19, 7:13AM CST
Reportlinker.com announces that a new market research report is available in its catalogue:
Spiral Energy Tech, Inc. Announces Patent Filing
ACCESSWIRE - Thu Nov 20, 5:16AM CST
LONG ISLAND, NY / ACCESSWIRE / November 20, 2014 / Spiral Energy Tech, Inc., ("SETI"
, a Fuse Science (OTC Pink: DROP) (PINKSHEETS: DROP) subsidiary, today announced that it has filed for Patent protection in the U.S. and foreign countries for the proprietary Drone support technology, Energy Demand Network or "EDEN". The proprietary technology enables the long distance flight required for drone based commerce without the need to return "home" every 15 minutes to recharge. The technology allows a drone operator to travel many miles outside of its "home range" allowing for a flight path of numerous miles limited only by our EDEN network of SkyPorts. This network is being developed for several states with planned nationwide deployment. Bankruptcies, Breakouts, and Busts; What's Happening in Biotech?
ACCESSWIRE - Tue Nov 11, 10:34AM CST
CORAL GABLES, FL / ACCESSWIRE / November 11, 2014 / From prostate cancer drugs to stem-cell therapy, the biotech industry seems to encompass a variety of unique and innovative companies. According to market research firm IBISWorld, the global revenue of the Biotech industry is nearly $300 billion. Statista reports that more that $50Billion of US biopharmaceutical goods are exported and the industry is on pace to grow at a compounded annual rate of nearly 11%. IBIS notes that many small companies, alongside a few industry giants in pharmaceutical, chemical and agricultural firms, populate the global biotech industry. There is also a lower level of market share concentration as noted by IBISWorld estimates that the top four industry players will account for less than 28% of the industry's revenue in 2014. With so much potential there are certainly companies in the market, which have progressed to the next level and others that have mismanaged their businesses into bankruptcy.
DNDN: 0.13 (-0.02)
Fuse Science, Inc. Announces Restructuring, Acquisition and Completion of $1.6 Million Financing
ACCESSWIRE - Thu Oct 09, 5:21AM CDT
LONG ISLAND, NY / ACCESSWIRE / October 9, 2014 / Fuse Science, Inc. (OTC Pink: DROP) (PINKSHEETS: DROP) (the "Company"
, today announced that it had completed a restructuring and financing with the purpose of supporting the Company's intent to expand its operations by entering into new lines of business. Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018
PR Newswire - Wed Feb 19, 7:13AM CST
Reportlinker.com announces that a new market research report is available in its catalogue:
